Viskase Holdings Inc (ENZN) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Viskase Holdings inc   (ENZN)
 

Viskase Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Viskase Holdings Inc 's inventory turnover ratio, the ratio that measures Viskase Holdings Inc 's ability to manage its supply chain, sequentially decreased to 2.4 in the third quarter 2026, but it does not raise any concerns as Viskase Holdings Inc continue to execute well, and the inventory turnover ratio remains above the average. Viskase Holdings Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 152 days, from 115 days, in the Jun 30 2026 quarter.

Within Healthcare sector Viskase Holdings inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

ENZN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Viskase Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENZN Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 1.73 % -7.72 % 2980 % - -
Inventory Turnover Ratio (TTM) 2.4 3.17 4.98 - -
ENZN's Total Ranking # # # # #
Average inventory processing period 152 115 73 - -
Seq. Inventory Growth -4.71 % 6.53 % -1.49 % - -
Seq. Cost of Sales Growth 9.8 % 2.64 % - - -0.41 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



ENZN Company Profile >> Back to ENZN Efficiency Comparisons >> Compare ENZN Inventory Turnover Ratio to its Competitors

Financial Statements
Viskase Holdings Inc 's Inventories $ 100 Millions Visit ENZN's Balance sheet
Viskase Holdings Inc 's Cost of Revenues TTM $ 243 Millions Visit ENZN's Income Statement
What are ENZN's Sales? Visit ENZN's Sales by Segment

Other Inventory Turnover Ratios
Viskase Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ENZN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ENZN's Competitors
Inventory Turnover Ratio for ENZN's Suppliers
Inventory Turnover Ratio for ENZN's Customers

You may also want to know
ENZN's Sales Growth Rates ENZN's Pe Price to earnings ratio ENZN's Receivables Turnover Ratio ENZN's Stock Quote
ENZN's Net Income Growth Rates ENZN's Ps Price to Sales ratio ENZN's Sales per Employee ENZN's Asset Turnover Ratio
ENZN's Net Margin ENZN's Pb Price to Book ratio ENZN's Financial Strength Ratios ENZN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions

Date modified: 2026-11-05T14:29:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.